Related Experiment Video
Updated: Feb 19, 2026

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice
Published on: October 24, 2018
Abrogated Freud-1/Cc2d1a Repression of 5-HT1A Autoreceptors Induces Fluoxetine-Resistant Anxiety/Depression-Like
Faranak Vahid-Ansari1, Mireille Daigle1, M Chiara Manzini2
1Ottawa Hospital Research Institute (Neuroscience), University of Ottawa Brain and Mind Research Institute, Ottawa, Ontario K1H-8M5, Canada.
Abstract:
Freud-1/Cc2d1a represses the gene transcription of serotonin-1A (5-HT1A) autoreceptors, which negatively regulate 5-HT tone. To test the role of Freud-1 in vivo, we generated mice with adulthood conditional knock-out of Freud-1 in 5-HT neurons (cF1ko). In cF1ko mice, 5-HT1A autoreceptor protein, binding and hypothermia response were increased, with reduced 5-HT content and neuronal activity in the dorsal raphe. The cF1ko mice displayed increased anxiety- and depression-like behavior that was resistant to chronic antidepressant (fluoxetine) treatment. Using conditional Freud-1/5-HT1A double knock-out (cF1/1A dko) to disrupt both Freud-1 and 5-HT1A genes in 5-HT neurons, no increase in anxiety- or depression-like behavior was seen upon knock-out of Freud-1 on the 5-HT1A autoreceptor-negative background; rather, a reduction in depression-like behavior emerged. These studies implicate transcriptional dysregulation of 5-HT1A autoreceptors by the repressor Freud-1 in anxiety and depression and provide a clinically relevant genetic model of antidepressant resistance. Targeting specific transcription factors, such as Freud-1, to restore transcriptional balance may augment response to antidepressant treatment.SIGNIFICANCE STATEMENT Altered regulation of the 5-HT1A autoreceptor has been implicated in human anxiety, major depression, suicide, and resistance to antidepressants. This study uniquely identifies a single transcription factor, Freud-1, as crucial for 5-HT1A autoreceptor expression in vivo Disruption of Freud-1 in serotonin neurons in mice links upregulation of 5-HT1A autoreceptors to anxiety/depression-like behavior and provides a new model of antidepressant resistance. Treatment strategies to reestablish transcriptional regulation of 5-HT1A autoreceptors could provide a more robust and sustained antidepressant response.
Insights
Freud-1 represses serotonin-1A (5-HT1A) autoreceptor transcription. Disrupting Freud-1 in mice increased 5-HT1A autoreceptors, leading to anxiety, depression, and antidepressant resistance, modeling treatment challenges.
Area of Science:
- Neuroscience
- Genetics
- Pharmacology
Background:
- Serotonin-1A (5-HT1A) autoreceptors regulate serotonin (5-HT) tone and are implicated in mood disorders.
- Altered 5-HT1A autoreceptor regulation is linked to human anxiety, depression, and antidepressant resistance.
Purpose of the Study:
- To investigate the in vivo role of the transcription factor Freud-1 in regulating 5-HT1A autoreceptors.
- To establish a genetic mouse model for studying anxiety, depression, and antidepressant resistance.
Main Methods:
- Generated conditional Freud-1 knockout (cF1ko) mice lacking Freud-1 in serotonin (5-HT) neurons.
- Assessed 5-HT1A autoreceptor expression, 5-HT levels, neuronal activity, and behavioral phenotypes (anxiety, depression).
- Utilized conditional Freud-1/5-HT1A double knockout (cF1/1A dko) mice to confirm Freud-1's role.
Main Results:
- cF1ko mice exhibited increased 5-HT1A autoreceptor levels, reduced 5-HT content, and dorsal raphe neuronal activity.
- cF1ko mice displayed heightened anxiety- and depression-like behaviors, resistant to fluoxetine treatment.
- cF1/1A dko mice showed no anxiety/depression increase upon Freud-1 knockout, indicating 5-HT1A autoreceptor mediation.
Conclusions:
- Transcriptional repression of 5-HT1A autoreceptors by Freud-1 is critical for normal anxiety and depression levels.
- Disruption of Freud-1 in 5-HT neurons leads to a mouse model of antidepressant resistance.
- Targeting transcription factors like Freud-1 may offer novel therapeutic strategies for mood disorders and antidepressant resistance.
Related Concept Videos
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Antidepressant Drugs: MAOIs and Other Agents
G-protein Coupled Receptors
Desensitization and Tachyphylaxis
Drugs Affecting Neurotransmitter Release or Uptake
Antidepressant Drugs: Overview

